Search results
Benefits of Roche diagnostic and management solutions for infectious diseases. Trusted expertise. Partnership & support. Comprehensive value. A pioneer and leader in in vitro diagnostics. At Roche, our vision is to empower laboratories for the future by streamlining design and simplifying processes.
The Roche Global Surveillance Program continuously monitors the genetic code of viruses, bacteria and parasites, to ensure tests are detecting the right targets and to aid in the design of the next generation of optimised diagnostics.
From screening and diagnosis to follow-up monitoring, people, laboratories, and point-of-care settings benefit from Roche’s comprehensive portfolio of infectious disease diagnostic solutions. Learn how innovation is helping healthcare systems meet demand.
Currently, Roche infectious diseases research and development is dedicated to finding effective treatment for a number of life-threatening infections that include viral hepatitis, influenza, multi-drug resistant bacteria, as well as COVID-19 and HIV/AIDs.
Deliver more results faster with fully automated molecular diagnostic systems, available in a range of testing volumes; Differentiate assay offerings with a flexible portfolio of lab developed testing (LDT) solutions; Personalise and standardise serology testing with integrated and modular clinical chemistry and immunochemistry analysers
Infectious Diseases Our comprehensive menu of diagnostic and research assays deliver accurate, reliable results each and every time. Explore our growing portfolio of assays and continue to trust your research to Roche.
People also ask
How can Roche help control infectious diseases?
Can improved diagnostic testing help prevent disease?
What are Roche estimates for IVD portfolio?
Enabler to sell high medical value biomarkers. Further consolidation of labs. Our aim to bring more & customer preference for menu to installed base fully automated solutions focusing on medical value. Increase of installed base for cobas® 6800/8800 in 2020.
